Naphazoline [2-(1-naphthyl-methyl-imidazoline)] as a curative for the treatment of keratitis punctata superficialis and dendritic keratitis.
D006801:Humans; D048288:Imidazolines; D007634:Keratitis / Q000628:therapy*; D007635:Keratitis, Dendritic; D009278:Naphazoline; D013566:Sympathomimetics / Q000627:therapeutic use*
D048288:Imidazolines; D013566:Sympathomimetics; D009278:Naphazoline
KERATITIS/therapy; SYMPATHOMIMETICS/therapeutic use